|
|
|
|
LEADER |
00000cam a2200000Mu 4500 |
001 |
EBOOKCENTRAL_ocn795119919 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr |n|---||||| |
008 |
120611s2011 xx o 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d MERUC
|d OCLCQ
|d ZCU
|d ICG
|d OCLCO
|d OCLCF
|d WYU
|d OCLCQ
|d DKC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
020 |
|
|
|a 9781608051649
|
020 |
|
|
|a 1608051641
|
029 |
1 |
|
|a DEBBG
|b BV044162587
|
035 |
|
|
|a (OCoLC)795119919
|
050 |
|
4 |
|a RS431.P38 .A385 2011
|
082 |
0 |
4 |
|a 615.19
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Atta-ur-Rahman.
|
245 |
1 |
0 |
|a Structure-Activity Relationship Studies in Drug Development by NMR Spectroscopy.
|
260 |
|
|
|a Sharjah :
|b Bentham Science Publishers,
|c 2011.
|
300 |
|
|
|a 1 online resource (221 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Cover; eBooks End User License Agreement; Contents; PREFACE; Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Author Index.
|
520 |
|
|
|a NMR (Nuclear Magnetic Resonance) Spectroscopy has found significant applications in drug discovery based on its capacity to map molecular interactions at the atomic level. Chemical shifts, cross relaxation, and exchange of protons are among the NMR parameters which are highly sensitive to the exact environment of the molecules, and therefore yield information about whether a small molecule (candidate compound) binds to a target protein (receptor) or to other macromolecules. These NMR parameters are also used to exactly map the part of the macromolecular target to which the ligand is bound. Spe.
|
588 |
0 |
|
|a Print version record.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Nuclear magnetic resonance spectroscopy.
|
650 |
|
0 |
|a Drugs
|x Design.
|
650 |
|
2 |
|a Magnetic Resonance Spectroscopy
|
650 |
|
2 |
|a Drug Design
|
650 |
|
6 |
|a Spectroscopie de la résonance magnétique nucléaire.
|
650 |
|
6 |
|a Médicaments
|x Conception.
|
650 |
|
7 |
|a Drugs
|x Design
|2 fast
|
650 |
|
7 |
|a Nuclear magnetic resonance spectroscopy
|2 fast
|
700 |
1 |
|
|a Choudhary, M. Iqbal.
|
758 |
|
|
|i has work:
|a Structure-Activity Relationship Studies in Drug Development by NMR Spectroscopy (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCXHbQ6RJwyrTJmK4fdfxym
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Atta-ur-Rahman.
|t Structure-Activity Relationship Studies in Drug Development by NMR Spectroscopy.
|d Sharjah : Bentham Science Publishers, ©2011
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=864220
|z Texto completo
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL864220
|
994 |
|
|
|a 92
|b IZTAP
|